United States / USD Country & Currency
Country
United States
Currency
US Dollars
Save
Country
Australia
Bahrain
Barbados
Cayman Islands
Cyprus
Falkland Islands
Gibraltar
Grenada
Guam
Hong Kong
India
Malaysia
Maldives
Malta
Martinique
Monaco
Montserrat
Namibia
Northern Ireland
Poland
Puerto Rico
Scotland
Singapore
St Lucia
St Vincent and the Grenadines
Switzerland
Taiwan
Thailand
United Kingdom
United States
Currency
US Dollars
GB Pounds
AU Dollars
Euro
Explore our range Categories
Ask us a question 877-271-6591 or 800-868-9064

Shipping delays due to Covid-19 Virus

Please fill the form to receive updates when we can ship your order.

Invokana (Canagliflozin) 100mg 10 Tablets/Pack


Invokana (Canagliflozin) 100mg 10 Tablets/Pack

Invokana (Canagliflozin) 100mg


Product Name
Invokana (Canagliflozin) 100mg 10 Tablets/Pack
Invokana 100mg
Active Ingredient
Canagliflozin 100mg
Manufacturer
Janssen Cilag
Product Type
Antihyperglycemic (Gliflozin class)
Product expiry date we are currently shipping
Apr 2023

Invokana tablets100mg contain canagliflozin an oral antihyperglycaemic used to improve glycaemic control in Type 2 Diabetes Mellitus (T2DM), when diet and exercise alone is not sufficient.  

Product Price List
REMEMBER SHIPPING IS FREE!

Invokana (Canagliflozin) 100mg 30 Tablets
$4.83 per Tablet
|
$145.00 (USD)
$145.00 (USD)
Invokana (Canagliflozin) 100mg 60 Tablets
$4.17 per Tablet
|
$250.00 (USD)
$250.00 (USD)
Invokana (Canagliflozin) 100mg 90 Tablets
$3.83 per Tablet
|
$345.00 (USD)
$345.00 (USD)
Invokana (Canagliflozin) 100mg 180 Tablets
$3.28 per Tablet
|
$590.00 (USD)
$590.00 (USD)

Invokana general information

What is Invokana used for?

Invokana tablets100mg are used to treat Type 2 Diabetes Mellitus (T2DM), also known as non-insulin-dependent diabetes to improve control of blood sugar levels (glycaemic control) when diet and exercise alone does not provide adequate glycaemic control.  T2DM is a disease characterised by high blood sugar levels (hyperglycaemia ) that are difficult to control (poor glycaemic control) due to chronic damage to the beta cells of the pancreas and loss of their normal function, which is the production of insulin in response to increase in blood glucose, particularly following a meal.  Insulin resistance is another reason for poor glycaemic control in T2DM.  Invokana tablets100mg are used in combination with improved diet and increased exercise and can be used as monotherapy or as add-on therapy with other oral antihyperglycaemic medications (metformin, a thiazolidinedione, a sulphonylurea or insulin), when diet and exercise, plus one of these other drugs does not provide adequate glycaemic control.  Invokana tablets100mg help restore glycaemic control and help prevent or delay the development of serious complications of T2DM.  These include cardiovascular disease leading to heart attack and stroke.  Also microvascular damage (damage to capillaries) in the eye, kidney or nerves can lead to diabetic retinopathy, nephropathy or neuropathy, which contributes to blindness, kidney disease, foot ulcers.  In extreme cases microvascular damage can result in amputation. 

How does Invokana work?

Invokana tablets100mg contain canagliflozin, an oral antihyperglycaemic belonging to the gliflozin group of drugs that work by inhibiting glucose reabsorption by the kidney.  Under normal conditions the kidneys filter glucose out of the blood into the proximal renal tubules where it is reabsorbed back into the blood to be used as an energy source by the body.  Renal glucose reabsorption is carried out by the transporter protein sodium-glucose co-transporter 2 (SGLT2), which is responsible for the majority of filtered glucose reabsorption in proximal tubule of the kidneys.  Sodium-glucose co-transporter 2 SGLT1, located further down the proximal tubule reabsorbs the remaining glucose.  Under normal conditions there should be no filtered glucose remaining in the urine.  However, when there is too much glucose in the blood, as is the case in T2DM, it cannot all be reabsorbed and the excess is excreted in the urine.  Also the capacity to reabsorb glucose is increased in T2DM, which contributes to hyperglycaemia. Canagliflozin in Invokana tablets100mg inhibit the action of SGLT2, which prevents glucose reabsorption and allows excess glucose to be excreted in the urine.  This results in reduced blood glucose levels and increased urinary glucose excretion; other health benefits include a reduction in blood pressure, due to increased diuretic effect (water loss) and reduced body weight due to a reduction in glucose availability.  Invokana tablets100mg reduce blood glucose levels and help maintain glycaemic control.

What does Invokana contain?

Invokana tablets100mg contain the active ingredient canagliflozin, an oral antihyperglycaemic used to improve glycaemic control in T2DM.  They also contain croscarmellose sodium, hydroxypropyl cellulose, lactose anhydrous, magnesium stearate, and microcrystalline cellulose. In addition, the tablet coating contains iron oxide yellow E172 (100 mg tablet only), macrogol/PEG, polyvinyl alcohol, talc, and titanium dioxide.

Treating Type 2 Diabetes Mellitus with Invokana

Invokana tablets100mg contain canagliflozin an oral antihyperglycaemic used to improve glycaemic control in T2DM, when diet and exercise alone is not sufficient to provide adequate glycaemic control.  T2DM is a disease characterised by high blood sugar levels (hyperglycaemia ) that are difficult to control (poor glycaemic control) due to chronic damage to the beta cells of the pancreas and loss of their normal function, which is the production of insulin in response to increase in blood glucose, particularly following a meal.  Insulin resistance is another reason for poor glycaemic control in T2DM.  Invokana tablets100mg are used in combination with improved diet and increased exercise and can be used as monotherapy or as add-on therapy with other oral antihyperglycaemic medications (metformin, a thiazolidinedione, a sulphonylurea or insulin), when diet and exercise, plus one of these other drugs does not provide adequate glycaemic control.  Canagliflozin in Invokana tablets100mg inhibits glucose reabsorption by the kidney and works by blocking the action of the sodium-glucose co-transporter 2 (SGLT2,) which is responsible for the majority of filtered glucose reabsorption in proximal tubule of the kidneys.  Under normal conditions the kidneys filter glucose out of the blood into the proximal renal tubules where it is reabsorbed back into the blood to be used as an energy source by the body.  In T2DM there is excess glucose in the blood and it cannot all be reabsorbed therefore, the excess is excreted in the urine.  Canagliflozin in Invokana tablets100mg prevents glucose reabsorption and allows excess glucose to be excreted in the urine.  This results in reduced blood glucose levels and increased urinary glucose excretion, which helps maintain glycaemic control.  Improving glycaemic control reduces risk of cardiovascular complications including microvascular damage (damage to capillaries) in the eye, kidney or nerves, which can lead to diabetic retinopathy, nephropathy or neuropathy, causing to blindness, kidney disease, foot ulcers and in extreme cases amputation. 

What are the side effects of Invokana?

The most commonly reported side effects when taking Invokana tablets100mg include: hypoglycaemia in combination with insulin or sulphonylurea, yeast infection of the vagina (vulvovaginal candidiasis) or penis (Balanitis, balanoposthitis), urinary tract infection, increased urination frequency and urinary amount, dehydration, thirst, constipation, nausea.

When should Invokana not be used?

You should not use Invokana tablets100mg if you:

  • are allergic to canagliflozin or any ingredients in Invokana
  • are pregnant or are breastfeeding
  • have type 1 (insulin dependent) diabetes
  • have diabetic ketoacidosis
  • have severe kidney or liver disease
  • are taking medicines that interact with Invokana, including the antiinfective rifampin for treatment of tuberculosis, digoxin for heart failure, the anticonvulsants phenytoin, carbamazepine or phenobarbital, ritonavir for HIV infection, diuretics (water pills), other antidiabetics like insulin or a sulphonylurea, cholestyramine for high cholesterol

What medications interact with Invokana?

Several medications interact with Invokana tablets100mg and should either not be taken while you are taking Invokana or only after discussion and instruction from your doctor:

  • Drugs that cause a serious reaction with Invokana: other antidiabetics like insulin or a sulphonylurea can cause hypoglycaemia (low blood sugar), diuretics can increase risk of dehydration and hypotension (low blood pressure)
  • Drugs that affect Invokana: rifampin for treatment of tuberculosis, the anticonvulsants phenytoin, carbamazepine or phenobarbital, ritonavir for HIV infection, cholestyramine for high cholesterol
  • Drugs that are affected by Invokana: digoxin for heart failure

How should Invokana be taken?

You should take your Invokana tablets100mg swallowed whole with a glass of water, once daily with or without food at the same time each day but preferably before the first meal of the day.  The dose you take depends on your doctor’s recommendation and you should continue with your prescribed diet and exercise programme.  You should continue to take your Invokana tablets100mg for as long as recommended by your doctor. 

How long should you take Invokana?

You should continue to take your Invokana tablets100mg for as long as recommended by your doctor. 

Missed dose of Invokana

If you miss a dose of Invokana tablets100mg take it as soon as you remember, unless it is time to take the next dose, then skip the missed dose.  Do not take a double dose.

How should Invokana be stored?

You should store your Invokana tablets100mg at 20- 25°C in a cool dry place.  

Other products in
Diabetes
 

This website uses cookies. View our policy and select your preferences here